zirconium has been researched along with Hematologic Malignancies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cho, EH; Choi, K; Chung, J; Chung, JH; Ju, JM; Kim, H; Kim, SY; Lee, SH; Lee, SJ; Oh, SJ; Ryu, JS; Sheen, JH; Soh, H | 1 |
1 other study(ies) available for zirconium and Hematologic Malignancies
Article | Year |
---|---|
Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
Topics: Cell Proliferation; Cell Survival; Deferoxamine; Hematologic Neoplasms; Humans; Immunoconjugates; Isothiocyanates; Isotope Labeling; Jurkat Cells; Leukocytes, Mononuclear; Positron-Emission Tomography; Radioisotopes; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; T-Lymphocytes; Tissue Distribution; Zirconium | 2020 |